Insights - An unexpected new contender in the race to develop a treatment for NASH (non-alcoholic steatohepatitis) emerged from a European medical conference on Thursday morning – the … Continue Reading
Read nowInsights - Teva (TEVA) made an official bid for rival drugmaker Mylan (MYL), which is in the middle of its own acquisition effort with a $29 billion bid for Perrigo (PRGO).
Read nowInsights - An experimental stem cell treatment from Athersys Inc. (ATHX) failed to improve recovery in patients who had experienced a stroke. ATHX dropped 50% with the data release. … Continue Reading
Read nowInsights - Aduro Biotech (ADRO) begins trading on Wednesday morning at 10:25 ET having completed a $119 million IPO that values the immunotherapy company at just over … Continue Reading
Read nowInsights - A week after the FDA modified a similar restriction on Tekmira Pharmaceuticals (TKMR), the federal agency has cleared Arrowhead Research (ARWR) to proceed with a multiple-dose Phase 2b clinical study … Continue Reading
Read nowResearch - It was just 5 days ago that Bristol-Myers Squibb (BMY) partnered with uniQure (QURE) on the discovery and development of novel gene therapies for cardiovascular … Continue Reading
Read nowInsights - Almost three years after an initial collaboration was announced, AstraZeneca (AZN) has selected the first clinical candidate from a discovery program with Regulus Therapeutics (RGLS). RGLS jumped … Continue Reading
Read now
